Contrast-enhanced ultrasonography of the prostate with sonazoid

Japanese Journal of Clinical Oncology

Volumn 40, Issue 11, 2010, Pages 1099-1104

  Matsumoto, Kazuhiro ^a   Nakagawa, Ken ^a   Hashiguchi, Akinori ^a   Kono, Hidaka ^a   Kikuchi, Eiji ^a   Nagata, Hirohiko ^a   Miyajima, Akira ^a   Oya, Mototsugu ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast medium; Prostate cancer; Sonazoid; Ultrasonography

Indexed keywords

PERFLUBUTANE; PROSTATE SPECIFIC ANTIGEN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; CONTRAST MEDIA; FERRIC COMPOUNDS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; MALE; MIDDLE AGED; OXIDES; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 78049438758     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq102     Document Type: Article

References (26)

1. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, et al. EAU guidelines on prostate cancer. Eur Urol 2008;53:68-80.
2. Frauscher F, Klauser A, Volgger H, Halpern EJ, Pallwein L, Steiner H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002;167:1648-52.
3. Roy C, Buy X, Lang H, Saussine C, Jacqmin D. Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumours and role for biopsy procedure. J Urol 2003;170:69-72.
4. Yi A, Kim JK, Park SH, Kim KW, Kim HS, Kim JH, et al. Contrastenhanced sonography for prostate cancer detection in patients with indeterminate clinical findings. Am J Roentgenol 2006;186:1431-5.
5. Pelzer A, Bektic J, Berger AP, Pallwein L, Halpern EJ, Horninger W, et al. Prostate cancer detection in men with prostate-specific antigen 4 to 10 ng/ml using a combined approach of contrast-enhanced color Doppler-targeted and systematic biopsy. J Urol 2005;173:1926-9.
6. Mitterberger M, Horninger W, Pelzer A, Strasser H, Bartsch G, Moser P, et al. A prospective randomized trial comparing contrastenhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection. Prostate 2007;67:1537-42.
7. Aigner F, Pallwein L, Mitterberger M, Pinggera GM, Mikuz G, Horninger W, et al. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 2009;103:458-63.
8. Halpern EJ, Ramey JR, Strup SE, Frauscher F, McCue P, Gomella LG. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 2005;104:2373-83.
9. Linden RA, Trabulsi EJ, Forsberg F, Gittens PR, Gomella LG, Halpern EJ. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. J Urol 2007;178:2354-8.
10. Halpern EJ, McCue PA, Aksnes AK, Hagen EK, Frauscher F, Gomella LG. Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology 2002;222:361-6.
11. Halpern EJ, Frauscher F, Rosenberg M, Gomella LG. Directed biopsy during contrast-enhanced sonography of the prostate. Am J Roentgenol 2002;178:915-9.
12. Epstein JI, Allsbrook WC, Jr, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29:1228-42.
13. Deering RE, Bigler SA, Brown M, Brawer MK. Microvascularity in benign prostate hyperplasia. Prostate 1995;26:111-5.
14. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006;175:1605-12.
15. Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol 2008;53:976-81.
16. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166:86-91.
17. Sieber PR, Rommel FM, Theodoran CG, Hong RD, Del Terzo MA. Contemporary prostate biopsy complication rates in community-based urology practice. Urology 2007;70:498-500.
18. Scattoni V, Zlotta A, Montironi R, Schulman C, Rigatti P, Montorsi F. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007;52:1309-22.
19. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993;24:220-6.
20. Weidner N, Carroll PR, Flax J, Blumenfeld W, Foldman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
21. Fregene TA, Khanuja PS, Noto AC, Gehani SK, Van Egmont EM, Luz DA, et al. Tumor-associated angiogenesis in prostate cancer. Anticancer Res 1993;13:2377-81.
22. Brawer MK, Deering RE, Brown M, Preston SD, Bigler S. Predictors of pathologic stage in prostate carcinoma, the role of neovascularity. Cancer 1994;73:678-87.
23. Bostwick DG, Wheeler TM, Blute M, Barrett DM, MacLennan GT, Sebo TJ, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996;48:47-57.
24. Lissbrant IF, Stattin P, Damber JE, Bergh A. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate 1997;33:38-45.
25. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998;78:940-4.
26. Mitterberger M, Pinggera GM, Horninger W, Bartsch G, Strasser H, Schäfer G, et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol 2007;178:464-8.